Kimberly-Clark (NYSE:KMB – Get Free Report) had its price target reduced by equities research analysts at UBS Group from $151.00 to $132.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s target price would indicate a potential upside of 3.67% from the company’s previous close.
Several other research firms have also recently commented on KMB. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $165.00 price target on shares of Kimberly-Clark in a report on Wednesday, October 23rd. Citigroup cut their target price on Kimberly-Clark from $125.00 to $118.00 and set a “sell” rating for the company in a research note on Wednesday. Barclays boosted their price target on shares of Kimberly-Clark from $135.00 to $144.00 and gave the company an “equal weight” rating in a report on Friday, October 11th. TD Cowen downgraded shares of Kimberly-Clark from a “buy” rating to a “hold” rating and set a $145.00 price objective for the company. in a report on Wednesday, January 8th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of Kimberly-Clark from $146.00 to $147.00 and gave the company a “hold” rating in a research note on Tuesday, October 8th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $143.71.
Read Our Latest Analysis on Kimberly-Clark
Kimberly-Clark Trading Up 0.5 %
Kimberly-Clark (NYSE:KMB – Get Free Report) last posted its quarterly earnings data on Tuesday, October 22nd. The company reported $1.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.69 by $0.14. Kimberly-Clark had a net margin of 12.97% and a return on equity of 198.59%. The company had revenue of $4.95 billion for the quarter, compared to the consensus estimate of $5.06 billion. During the same quarter in the previous year, the firm posted $1.74 EPS. The business’s revenue was down 3.5% compared to the same quarter last year. As a group, sell-side analysts predict that Kimberly-Clark will post 7.31 EPS for the current year.
Insider Transactions at Kimberly-Clark
In related news, VP Andrew Drexler sold 3,000 shares of Kimberly-Clark stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $139.01, for a total value of $417,030.00. Following the completion of the transaction, the vice president now directly owns 5,053 shares of the company’s stock, valued at $702,417.53. The trade was a 37.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.62% of the stock is owned by company insiders.
Institutional Investors Weigh In On Kimberly-Clark
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. William B. Walkup & Associates Inc. acquired a new stake in shares of Kimberly-Clark in the second quarter valued at approximately $26,000. Darwin Wealth Management LLC bought a new position in Kimberly-Clark in the 3rd quarter valued at $29,000. DiNuzzo Private Wealth Inc. increased its stake in shares of Kimberly-Clark by 808.0% in the 3rd quarter. DiNuzzo Private Wealth Inc. now owns 227 shares of the company’s stock valued at $32,000 after buying an additional 202 shares during the period. Kennebec Savings Bank bought a new stake in shares of Kimberly-Clark during the third quarter worth $36,000. Finally, ORG Wealth Partners LLC acquired a new position in shares of Kimberly-Clark during the third quarter valued at $39,000. Institutional investors and hedge funds own 76.29% of the company’s stock.
Kimberly-Clark Company Profile
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Recommended Stories
- Five stocks we like better than Kimberly-Clark
- Are Penny Stocks a Good Fit for Your Portfolio?
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- What is the Euro STOXX 50 Index?
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- The 3 Best Blue-Chip Stocks to Buy Now
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.